A Novel Dual-Cab Nectin-4 X CD3 Bispecific Antibody Targeting Solid Tumors

April 25, 2023

NextGen Conditionally Active Biologic (CAB) ADCs: Improved Stability and Safety

April 17, 2023

A Novel Dual-Cab Nectin-4 X CD3 Bispecific Antibody Targeting Solid Tumors

April 17, 2023

NextGen Conditionally Active Biologic (CAB) ADCs: Improved Stability and Safety

February 2, 2023

Novel Conditionally Active Bispecific T Cell Engagers Targeting Solid Tumors

February 2, 2023

Novel conditionally active ADCs (CAB ADCs): A novel class of molecules targeting solid tumors

February 2, 2023